Zynerba Pharmaceuticals Ord Shs (ZYNE)
$3.42 0.17 (5.23%)
19:25 EDT ZYNE Stock Quote Delayed 30 Minutes
Previous Close $3.42
Market Cap 46.38M
PE Ratio -1.23
Volume (Avg. Vol.) 1.49M
Day's Range 3.20 - 3.44
52-Week Range 2.55 - 15.30
Dividend & Yield N/A (N/A)
ZYNE Stock Predictions, Articles, and Zynerba Pharmaceuticals Ord Shs News
- From InvestorPlace
- From the Web
Investors are looking for the stocks that have the potential to lift their portfolios to new heights. These investments are the stocks with the strongest long-term growth narratives, capable of delivering massive returns.
Thinking about investing in medical cannabis? ZYNE stock is a lesser-known gem with transformative potential.
We are on the brink of a massive market opportunity. For instance, a new report by Grand View Research reveals that the global legal marijuana market size is expected to reach $66.3 billion by the end of 2025.
Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.
Investors have heard a ton about cannabis stocks and their ridiculous valuations. But Wall Street analysts say these pot stocks still have a lot of upside ahead.
Zynerba has a CBD gel that looks like a promising treatment for various neurological diseases. What does it mean for ZYNE stock?
There's some positive Zynerba Pharmaceuticals news concerning ZYNE stock on Tuesday that has it soaring to incredible heights.
Zynerba Pharmaceuticals (ZYNE) stock isn't done with its recent rally yet as the stock continues to climb higher on Thursday.
InvestorPlace's Best Stocks Contest is entering the homestretch! Here's how our experts' picks are holding up through the third quarter.
3 Stocks to Watch on Monday: Alphabet Inc (GOOGL), Zynerba Pharmaceuticals Inc (ZYNE) and Sony Corp (ADR) (SNE)
Zynerba Pharmaceuticals (ZYNE) crashes by nearly half, Alphabet (GOOGL) responds to anti-diversity letter and Sony (SNE) suffers yet another box-office disappointment.
Former leaders have fallen and former laggards in the Best Stocks for 2017 contest have risen to the occasion -- check out the rankings!
The experts' pick in the 10 Best Stocks for 2017 contest are trouncing the market so far. But where will these stocks to buy go from here?
Zynerba is working to bring its marijuana-based medications through trials and investors seem to be rewarding ZYNE stock.
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
It’s easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make higher profits, but you also face the risk of<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/volatility-101-should-randolph-bancorp-nasdaqrndb-shares-have-dropped-38/">Read More...</a></div>
Analysts Offer Insights on Financial Companies: Marketaxess Holdings (NASDAQ: MKTX), Host Hotels & Resorts (NYSE: HST) and Randolph Bancorp (NASDAQ: RNDB)
From Analyst Ratings
Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Marketaxess Holdings (MKTX – Research Report), Host Hotels & Resorts (HST – Research Report) and Randolph Bancorp (RNDB – Research Report). Marketaxess Holdings (MKTX) In a report released today, Brian Bedell from Deutsche Bank maintained a Hold rating
If you’re interested in Randolph Bancorp, Inc. (NASDAQ:RNDB), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/does-the-randolph-bancorp-inc-nasdaqrndb-share-price-fall-with-the-market/">Read More...</a></div>
A look at the shareholders of Randolph Bancorp, Inc. (NASDAQ:RNDB) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/what-kind-of-shareholder-owns-most-randolph-bancorp-inc-nasdaqrndb-stock-3/">Read More...</a></div>
Jim McDonough has been the CEO of Randolph Bancorp, Inc. (NASDAQ:RNDB) since 2013. First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/is-randolph-bancorp-inc-s-nasdaqrndb-ceo-overpaid-relative-to-its-peers/">Read More...</a></div>
One way to deal with stock volatility is to ensure you have a properly diverse portfolio. Of course, the aim of the game is to pick stocks that do better<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/did-you-miss-randolph-bancorps-nasdaqrndb-19-share-price-gain/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader